Rare
lephants
Screener
Toggle theme
Insulet Corp.
PODD
·
Healthcare, Medical Devices, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2020
FY2019
FY2018
FY2017
FY2016
FY2014
FY2013
Total Cash from Operations:
$569.3M
Line Item
Value
% of Total
Capital Expenditures
$155.0M
27.2%
Stock Repurchases
$59.6M
10.5%
Other Financing
$354.7M
62.3%
Net Cash Flow
$0
0.0%
Download CSV
